0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma Grade Evening Primrose Oil Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-24R16435
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma Grade Evening Primrose Oil Market Research Report 2024
BUY CHAPTERS

Global Pharma Grade Evening Primrose Oil Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-24R16435
Report
November 2025
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharma Grade Evening Primrose Oil Market Size

The global Pharma Grade Evening Primrose Oil market is projected to grow from US$ 124 million in 2024 to US$ 173 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Pharma Grade Evening Primrose Oil Market

Pharma Grade Evening Primrose Oil Market

Used medicinally, Evening Primrose Oil is reputed to ease headaches, dizziness, muscular aches and weakness, tiredness and slowed reflexes, and irritability. It is believed to promote clear-headedness, decisiveness, and concentration while improving coordination, appetite, immunity, memory, sensuality, and vigor.
From a downstream perspective, Skin Disorders accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharma Grade Evening Primrose Oil leading manufacturers including Sanmark, Shengji-oils, Bailibiotech, Lnjiashi, Hebei Xinqidian, Tianshans, Panjin Tianyuan Pharmaceutical, Henry Lamotte, Connoils, OLEADOR GMBH, etc., dominate supply; the top five capture approximately % of global revenue, with Sanmark leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharma Grade Evening Primrose Oil market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharma Grade Evening Primrose Oil Market Report

Report Metric Details
Report Name Pharma Grade Evening Primrose Oil Market
Accounted market size in 2024 US$ 124 million
Forecasted market size in 2031 US$ 173 million
CAGR 4.9%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Content ≤99%
  • Content >99%
Segment by Application
  • Skin Disorders
  • psychological Illness
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanmark, Shengji-oils, Bailibiotech, Lnjiashi, Hebei Xinqidian, Tianshans, Panjin Tianyuan Pharmaceutical, Henry Lamotte, Connoils, OLEADOR GMBH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharma Grade Evening Primrose Oil study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Pharma Grade Evening Primrose Oil Market growing?

Ans: The Pharma Grade Evening Primrose Oil Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Pharma Grade Evening Primrose Oil Market size in 2031?

Ans: The Pharma Grade Evening Primrose Oil Market size in 2031 will be US$ 173 million.

Who are the main players in the Pharma Grade Evening Primrose Oil Market report?

Ans: The main players in the Pharma Grade Evening Primrose Oil Market are Sanmark, Shengji-oils, Bailibiotech, Lnjiashi, Hebei Xinqidian, Tianshans, Panjin Tianyuan Pharmaceutical, Henry Lamotte, Connoils, OLEADOR GMBH

What are the Application segmentation covered in the Pharma Grade Evening Primrose Oil Market report?

Ans: The Applications covered in the Pharma Grade Evening Primrose Oil Market report are Skin Disorders, psychological Illness, Others

What are the Type segmentation covered in the Pharma Grade Evening Primrose Oil Market report?

Ans: The Types covered in the Pharma Grade Evening Primrose Oil Market report are Content ≤99%, Content >99%

1 Study Coverage
1.1 Introduction to Pharma Grade Evening Primrose Oil: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharma Grade Evening Primrose Oil Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Content ≤99%
1.2.3 Content >99%
1.3 Market Segmentation by Application
1.3.1 Global Pharma Grade Evening Primrose Oil Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Skin Disorders
1.3.3 psychological Illness
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharma Grade Evening Primrose Oil Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharma Grade Evening Primrose Oil Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharma Grade Evening Primrose Oil Sales Estimates and Forecasts 2020-2031
2.4 Global Pharma Grade Evening Primrose Oil Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Pharma Grade Evening Primrose Oil Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Pharma Grade Evening Primrose Oil Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Pharma Grade Evening Primrose Oil Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Content ≤99% Market Size by Manufacturers
4.5.2 Content >99% Market Size by Manufacturers
4.6 Global Pharma Grade Evening Primrose Oil Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Pharma Grade Evening Primrose Oil Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Pharma Grade Evening Primrose Oil Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Pharma Grade Evening Primrose Oil Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Pharma Grade Evening Primrose Oil Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Pharma Grade Evening Primrose Oil Sales and Revenue by Type (2020-2031)
7.4 North America Pharma Grade Evening Primrose Oil Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Pharma Grade Evening Primrose Oil Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Pharma Grade Evening Primrose Oil Sales and Revenue by Type (2020-2031)
8.4 Europe Pharma Grade Evening Primrose Oil Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Pharma Grade Evening Primrose Oil Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Pharma Grade Evening Primrose Oil Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Pharma Grade Evening Primrose Oil Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Pharma Grade Evening Primrose Oil Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Pharma Grade Evening Primrose Oil Sales and Revenue by Type (2020-2031)
10.4 Central and South America Pharma Grade Evening Primrose Oil Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Pharma Grade Evening Primrose Oil Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Pharma Grade Evening Primrose Oil Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Pharma Grade Evening Primrose Oil Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Pharma Grade Evening Primrose Oil Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Sanmark
12.1.1 Sanmark Corporation Information
12.1.2 Sanmark Business Overview
12.1.3 Sanmark Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.1.4 Sanmark Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Sanmark Pharma Grade Evening Primrose Oil Sales by Product in 2024
12.1.6 Sanmark Pharma Grade Evening Primrose Oil Sales by Application in 2024
12.1.7 Sanmark Pharma Grade Evening Primrose Oil Sales by Geographic Area in 2024
12.1.8 Sanmark Pharma Grade Evening Primrose Oil SWOT Analysis
12.1.9 Sanmark Recent Developments
12.2 Shengji-oils
12.2.1 Shengji-oils Corporation Information
12.2.2 Shengji-oils Business Overview
12.2.3 Shengji-oils Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.2.4 Shengji-oils Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Shengji-oils Pharma Grade Evening Primrose Oil Sales by Product in 2024
12.2.6 Shengji-oils Pharma Grade Evening Primrose Oil Sales by Application in 2024
12.2.7 Shengji-oils Pharma Grade Evening Primrose Oil Sales by Geographic Area in 2024
12.2.8 Shengji-oils Pharma Grade Evening Primrose Oil SWOT Analysis
12.2.9 Shengji-oils Recent Developments
12.3 Bailibiotech
12.3.1 Bailibiotech Corporation Information
12.3.2 Bailibiotech Business Overview
12.3.3 Bailibiotech Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.3.4 Bailibiotech Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Bailibiotech Pharma Grade Evening Primrose Oil Sales by Product in 2024
12.3.6 Bailibiotech Pharma Grade Evening Primrose Oil Sales by Application in 2024
12.3.7 Bailibiotech Pharma Grade Evening Primrose Oil Sales by Geographic Area in 2024
12.3.8 Bailibiotech Pharma Grade Evening Primrose Oil SWOT Analysis
12.3.9 Bailibiotech Recent Developments
12.4 Lnjiashi
12.4.1 Lnjiashi Corporation Information
12.4.2 Lnjiashi Business Overview
12.4.3 Lnjiashi Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.4.4 Lnjiashi Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Lnjiashi Pharma Grade Evening Primrose Oil Sales by Product in 2024
12.4.6 Lnjiashi Pharma Grade Evening Primrose Oil Sales by Application in 2024
12.4.7 Lnjiashi Pharma Grade Evening Primrose Oil Sales by Geographic Area in 2024
12.4.8 Lnjiashi Pharma Grade Evening Primrose Oil SWOT Analysis
12.4.9 Lnjiashi Recent Developments
12.5 Hebei Xinqidian
12.5.1 Hebei Xinqidian Corporation Information
12.5.2 Hebei Xinqidian Business Overview
12.5.3 Hebei Xinqidian Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.5.4 Hebei Xinqidian Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Hebei Xinqidian Pharma Grade Evening Primrose Oil Sales by Product in 2024
12.5.6 Hebei Xinqidian Pharma Grade Evening Primrose Oil Sales by Application in 2024
12.5.7 Hebei Xinqidian Pharma Grade Evening Primrose Oil Sales by Geographic Area in 2024
12.5.8 Hebei Xinqidian Pharma Grade Evening Primrose Oil SWOT Analysis
12.5.9 Hebei Xinqidian Recent Developments
12.6 Tianshans
12.6.1 Tianshans Corporation Information
12.6.2 Tianshans Business Overview
12.6.3 Tianshans Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.6.4 Tianshans Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Tianshans Recent Developments
12.7 Panjin Tianyuan Pharmaceutical
12.7.1 Panjin Tianyuan Pharmaceutical Corporation Information
12.7.2 Panjin Tianyuan Pharmaceutical Business Overview
12.7.3 Panjin Tianyuan Pharmaceutical Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.7.4 Panjin Tianyuan Pharmaceutical Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Panjin Tianyuan Pharmaceutical Recent Developments
12.8 Henry Lamotte
12.8.1 Henry Lamotte Corporation Information
12.8.2 Henry Lamotte Business Overview
12.8.3 Henry Lamotte Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.8.4 Henry Lamotte Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Henry Lamotte Recent Developments
12.9 Connoils
12.9.1 Connoils Corporation Information
12.9.2 Connoils Business Overview
12.9.3 Connoils Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.9.4 Connoils Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Connoils Recent Developments
12.10 OLEADOR GMBH
12.10.1 OLEADOR GMBH Corporation Information
12.10.2 OLEADOR GMBH Business Overview
12.10.3 OLEADOR GMBH Pharma Grade Evening Primrose Oil Product Models, Descriptions and Specifications
12.10.4 OLEADOR GMBH Pharma Grade Evening Primrose Oil Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 OLEADOR GMBH Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Pharma Grade Evening Primrose Oil Industry Chain
13.2 Pharma Grade Evening Primrose Oil Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Pharma Grade Evening Primrose Oil Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Pharma Grade Evening Primrose Oil Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Pharma Grade Evening Primrose Oil Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Pharma Grade Evening Primrose Oil Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Pharma Grade Evening Primrose Oil Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharma Grade Evening Primrose Oil Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharma Grade Evening Primrose Oil Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharma Grade Evening Primrose Oil Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pharma Grade Evening Primrose Oil Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Pharma Grade Evening Primrose Oil Sales by Region (2020-2025) & (Tons)
 Table 8. Global Pharma Grade Evening Primrose Oil Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pharma Grade Evening Primrose Oil Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Pharma Grade Evening Primrose Oil Production by Region (2020-2025) & (Tons)
 Table 12. Global Pharma Grade Evening Primrose Oil Production by Region (2026-2031) & (Tons)
 Table 13. Global Pharma Grade Evening Primrose Oil Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Pharma Grade Evening Primrose Oil Sales Share by Manufacturers (2020-2025)
 Table 15. Global Pharma Grade Evening Primrose Oil Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Pharma Grade Evening Primrose Oil Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Pharma Grade Evening Primrose Oil by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Grade Evening Primrose Oil as of 2024)
 Table 19. Global Pharma Grade Evening Primrose Oil Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Pharma Grade Evening Primrose Oil Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Pharma Grade Evening Primrose Oil Manufacturing Base and Headquarters
 Table 22. Global Pharma Grade Evening Primrose Oil Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Pharma Grade Evening Primrose Oil Sales by Type (2020-2025) & (Tons)
 Table 26. Global Pharma Grade Evening Primrose Oil Sales by Type (2026-2031) & (Tons)
 Table 27. Global Pharma Grade Evening Primrose Oil Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Pharma Grade Evening Primrose Oil Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Pharma Grade Evening Primrose Oil ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Pharma Grade Evening Primrose Oil Sales by Application (2020-2025) & (Tons)
 Table 32. Global Pharma Grade Evening Primrose Oil Sales by Application (2026-2031) & (Tons)
 Table 33. Pharma Grade Evening Primrose Oil High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Pharma Grade Evening Primrose Oil Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Pharma Grade Evening Primrose Oil Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Pharma Grade Evening Primrose Oil ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Pharma Grade Evening Primrose Oil Growth Accelerators and Market Barriers
 Table 40. North America Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Pharma Grade Evening Primrose Oil Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Pharma Grade Evening Primrose Oil Growth Accelerators and Market Barriers
 Table 43. Europe Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Pharma Grade Evening Primrose Oil Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Pharma Grade Evening Primrose Oil Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Pharma Grade Evening Primrose Oil Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Pharma Grade Evening Primrose Oil Investment Opportunities and Key Challenges
 Table 50. Central and South America Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Pharma Grade Evening Primrose Oil Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Pharma Grade Evening Primrose Oil Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Sanmark Corporation Information
 Table 54. Sanmark Description and Major Businesses
 Table 55. Sanmark Product Models, Descriptions and Specifications
 Table 56. Sanmark Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Sanmark Sales Value Proportion by Product in 2024
 Table 58. Sanmark Sales Value Proportion by Application in 2024
 Table 59. Sanmark Sales Value Proportion by Geographic Area in 2024
 Table 60. Sanmark Pharma Grade Evening Primrose Oil SWOT Analysis
 Table 61. Sanmark Recent Developments
 Table 62. Shengji-oils Corporation Information
 Table 63. Shengji-oils Description and Major Businesses
 Table 64. Shengji-oils Product Models, Descriptions and Specifications
 Table 65. Shengji-oils Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Shengji-oils Sales Value Proportion by Product in 2024
 Table 67. Shengji-oils Sales Value Proportion by Application in 2024
 Table 68. Shengji-oils Sales Value Proportion by Geographic Area in 2024
 Table 69. Shengji-oils Pharma Grade Evening Primrose Oil SWOT Analysis
 Table 70. Shengji-oils Recent Developments
 Table 71. Bailibiotech Corporation Information
 Table 72. Bailibiotech Description and Major Businesses
 Table 73. Bailibiotech Product Models, Descriptions and Specifications
 Table 74. Bailibiotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Bailibiotech Sales Value Proportion by Product in 2024
 Table 76. Bailibiotech Sales Value Proportion by Application in 2024
 Table 77. Bailibiotech Sales Value Proportion by Geographic Area in 2024
 Table 78. Bailibiotech Pharma Grade Evening Primrose Oil SWOT Analysis
 Table 79. Bailibiotech Recent Developments
 Table 80. Lnjiashi Corporation Information
 Table 81. Lnjiashi Description and Major Businesses
 Table 82. Lnjiashi Product Models, Descriptions and Specifications
 Table 83. Lnjiashi Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Lnjiashi Sales Value Proportion by Product in 2024
 Table 85. Lnjiashi Sales Value Proportion by Application in 2024
 Table 86. Lnjiashi Sales Value Proportion by Geographic Area in 2024
 Table 87. Lnjiashi Pharma Grade Evening Primrose Oil SWOT Analysis
 Table 88. Lnjiashi Recent Developments
 Table 89. Hebei Xinqidian Corporation Information
 Table 90. Hebei Xinqidian Description and Major Businesses
 Table 91. Hebei Xinqidian Product Models, Descriptions and Specifications
 Table 92. Hebei Xinqidian Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Hebei Xinqidian Sales Value Proportion by Product in 2024
 Table 94. Hebei Xinqidian Sales Value Proportion by Application in 2024
 Table 95. Hebei Xinqidian Sales Value Proportion by Geographic Area in 2024
 Table 96. Hebei Xinqidian Pharma Grade Evening Primrose Oil SWOT Analysis
 Table 97. Hebei Xinqidian Recent Developments
 Table 98. Tianshans Corporation Information
 Table 99. Tianshans Description and Major Businesses
 Table 100. Tianshans Product Models, Descriptions and Specifications
 Table 101. Tianshans Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Tianshans Recent Developments
 Table 103. Panjin Tianyuan Pharmaceutical Corporation Information
 Table 104. Panjin Tianyuan Pharmaceutical Description and Major Businesses
 Table 105. Panjin Tianyuan Pharmaceutical Product Models, Descriptions and Specifications
 Table 106. Panjin Tianyuan Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Panjin Tianyuan Pharmaceutical Recent Developments
 Table 108. Henry Lamotte Corporation Information
 Table 109. Henry Lamotte Description and Major Businesses
 Table 110. Henry Lamotte Product Models, Descriptions and Specifications
 Table 111. Henry Lamotte Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Henry Lamotte Recent Developments
 Table 113. Connoils Corporation Information
 Table 114. Connoils Description and Major Businesses
 Table 115. Connoils Product Models, Descriptions and Specifications
 Table 116. Connoils Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Connoils Recent Developments
 Table 118. OLEADOR GMBH Corporation Information
 Table 119. OLEADOR GMBH Description and Major Businesses
 Table 120. OLEADOR GMBH Product Models, Descriptions and Specifications
 Table 121. OLEADOR GMBH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. OLEADOR GMBH Recent Developments
 Table 123. Key Raw Materials Distribution
 Table 124. Raw Materials Key Suppliers
 Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 126. Milestones in Production Technology Evolution
 Table 127. Distributors List
 Table 128. Market Trends and Market Evolution
 Table 129. Market Drivers and Opportunities
 Table 130. Market Challenges, Risks, and Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharma Grade Evening Primrose Oil Product Picture
 Figure 2. Global Pharma Grade Evening Primrose Oil Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Content ≤99% Product Picture
 Figure 4. Content >99% Product Picture
 Figure 5. Global Pharma Grade Evening Primrose Oil Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Skin Disorders
 Figure 7. psychological Illness
 Figure 8. Others
 Figure 9. Pharma Grade Evening Primrose Oil Report Years Considered
 Figure 10. Global Pharma Grade Evening Primrose Oil Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Pharma Grade Evening Primrose Oil Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Pharma Grade Evening Primrose Oil Revenue Market Share by Region (2020-2031)
 Figure 14. Global Pharma Grade Evening Primrose Oil Sales (2020-2031) & (Tons)
 Figure 15. Global Pharma Grade Evening Primrose Oil Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Pharma Grade Evening Primrose Oil Sales Market Share by Region (2020-2031)
 Figure 17. Global Pharma Grade Evening Primrose Oil Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global Pharma Grade Evening Primrose Oil Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global Pharma Grade Evening Primrose Oil Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. Pharma Grade Evening Primrose Oil Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. Pharma Grade Evening Primrose Oil Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. Pharma Grade Evening Primrose Oil Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. Pharma Grade Evening Primrose Oil Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers Pharma Grade Evening Primrose Oil Sales Volume Market Share in 2024
 Figure 26. Global Pharma Grade Evening Primrose Oil Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Content ≤99% Revenue Market Share by Manufacturer in 2024
 Figure 29. Content >99% Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global Pharma Grade Evening Primrose Oil Sales Market Share by Type (2020-2031)
 Figure 33. Global Pharma Grade Evening Primrose Oil Revenue Market Share by Type (2020-2031)
 Figure 34. Global Pharma Grade Evening Primrose Oil Sales Market Share by Application (2020-2031)
 Figure 35. Global Pharma Grade Evening Primrose Oil Revenue Market Share by Application (2020-2031)
 Figure 36. North America Pharma Grade Evening Primrose Oil Sales YoY (2020-2031) & (Tons)
 Figure 37. North America Pharma Grade Evening Primrose Oil Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) in 2024
 Figure 39. North America Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Pharma Grade Evening Primrose Oil Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe Pharma Grade Evening Primrose Oil Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) in 2024
 Figure 49. Europe Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 54. France Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific Pharma Grade Evening Primrose Oil Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific Pharma Grade Evening Primrose Oil Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 69. India Pharma Grade Evening Primrose Oil Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America Pharma Grade Evening Primrose Oil Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America Pharma Grade Evening Primrose Oil Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil Pharma Grade Evening Primrose Oil Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina Pharma Grade Evening Primrose Oil Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa Pharma Grade Evening Primrose Oil Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa Pharma Grade Evening Primrose Oil Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa Pharma Grade Evening Primrose Oil Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa Pharma Grade Evening Primrose Oil Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries Pharma Grade Evening Primrose Oil Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey Pharma Grade Evening Primrose Oil Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt Pharma Grade Evening Primrose Oil Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa Pharma Grade Evening Primrose Oil Revenue (2020-2025) & (US$ Million)
 Figure 90. Pharma Grade Evening Primrose Oil Industry Chain Mapping
 Figure 91. Regional Pharma Grade Evening Primrose Oil Manufacturing Base Distribution (%)
 Figure 92. Pharma Grade Evening Primrose Oil Production Process
 Figure 93. Regional Pharma Grade Evening Primrose Oil Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure